NDC 55566-1000
Ganirelix Acetate
Ganirelix Acetate
Ganirelix Acetate is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Ferring Pharmaceuticals Inc.. The primary component is Ganirelix Acetate.
Product ID | 55566-1000_443a2d58-f4f2-4597-8cb0-14db3b050008 |
NDC | 55566-1000 |
Product Type | Human Prescription Drug |
Proprietary Name | Ganirelix Acetate |
Generic Name | Ganirelix Acetate |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2019-01-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA204246 |
Labeler Name | FERRING PHARMACEUTICALS INC. |
Substance Name | GANIRELIX ACETATE |
Active Ingredient Strength | 250 ug/.5mL |
Pharm Classes | Decreased GnRH Secretion [PE],Gonadotropin Releasing Hormone Antagonist [EPC],Gonadotropin Releasing Hormone Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |